Daniel W. Chan

16.5k total citations · 3 hit papers
161 papers, 9.4k citations indexed

About

Daniel W. Chan is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Spectroscopy. According to data from OpenAlex, Daniel W. Chan has authored 161 papers receiving a total of 9.4k indexed citations (citations by other indexed papers that have themselves been cited), including 64 papers in Molecular Biology, 51 papers in Pulmonary and Respiratory Medicine and 40 papers in Spectroscopy. Recurrent topics in Daniel W. Chan's work include Prostate Cancer Diagnosis and Treatment (41 papers), Prostate Cancer Treatment and Research (40 papers) and Advanced Proteomics Techniques and Applications (39 papers). Daniel W. Chan is often cited by papers focused on Prostate Cancer Diagnosis and Treatment (41 papers), Prostate Cancer Treatment and Research (40 papers) and Advanced Proteomics Techniques and Applications (39 papers). Daniel W. Chan collaborates with scholars based in United States, Netherlands and Canada. Daniel W. Chan's co-authors include Lori J. Sokoll, Peter B. Luppa, Danni Li, Alan W. Partin, Martin G. Sanda, Leong L. Ng, Eric T. Fung, Hui Zhang, Zhen Zhang and Harry G. Rittenhouse and has published in prestigious journals such as New England Journal of Medicine, Circulation and Nature Medicine.

In The Last Decade

Daniel W. Chan

156 papers receiving 9.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Three Biomarkers Identified from Serum Proteomic Analysis for the Detection of Early Stage Ovarian Cancer

2004 741 citations Zhen Zhang, Robert C. Bast et al. Cancer Research profile →
Standard Operating Procedures for Serum and Plasma Collection: Early Detection Research Network Consensus Statement Standard Operating Procedure Integration Working Group

2008 568 citations Daniel W. Chan et al. profile →
Immunosensors—principles and applications to clinical chemistry

2001 512 citations Lori J. Sokoll, Daniel W. Chan et al. Clinica Chimica Acta profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Daniel W. Chan United States	50	4.1k	2.6k	2.0k	1.4k	1.1k	161	9.4k
Lori J. Sokoll United States	54	3.8k 0.9×	4.6k 1.8×	1.1k 0.5×	3.3k 2.4×	2.3k 2.0×	231	12.4k
Kim Pettersson Finland	58	3.4k 0.8×	3.6k 1.4×	492 0.2×	905 0.6×	956 0.8×	291	10.9k
Rosamonde E. Banks United Kingdom	51	5.1k 1.2×	1.4k 0.5×	1.7k 0.9×	1.6k 1.1×	1.5k 1.3×	162	8.8k
George L. Wright United States	42	2.5k 0.6×	2.2k 0.8×	1.7k 0.9×	461 0.3×	837 0.7×	135	6.8k
Theo M. Luider Netherlands	48	4.8k 1.2×	695 0.3×	1.9k 0.9×	1.3k 0.9×	958 0.8×	268	8.1k
John A. Petros United States	46	4.9k 1.2×	3.3k 1.3×	310 0.2×	1.8k 1.2×	1.3k 1.1×	133	10.9k
Bruce Furie United States	72	5.6k 1.4×	1.9k 0.7×	527 0.3×	1.6k 1.1×	1.3k 1.2×	238	19.1k
Barbara C. Furie United States	58	4.1k 1.0×	1.6k 0.6×	398 0.2×	1.3k 0.9×	1.0k 0.9×	156	14.8k
Dan Theodorescu United States	69	7.5k 1.8×	3.1k 1.2×	739 0.4×	2.8k 2.0×	3.6k 3.1×	335	14.6k
Helmut Klocker Austria	67	6.9k 1.7×	6.6k 2.5×	495 0.2×	3.1k 2.2×	3.0k 2.6×	364	15.1k

Countries citing papers authored by Daniel W. Chan

Since Specialization

Citations

This map shows the geographic impact of Daniel W. Chan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel W. Chan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel W. Chan more than expected).

Fields of papers citing papers by Daniel W. Chan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daniel W. Chan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel W. Chan. The network helps show where Daniel W. Chan may publish in the future.

Co-authorship network of co-authors of Daniel W. Chan

This figure shows the co-authorship network connecting the top 25 collaborators of Daniel W. Chan. A scholar is included among the top collaborators of Daniel W. Chan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Daniel W. Chan. Daniel W. Chan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Shore, Neal D., Christopher Pieczonka, Ralph J. Henderson, et al.. (2020). Development and evaluation of the MiCheck test for aggressive prostate cancer. Urologic Oncology Seminars and Original Investigations. 38(8). 683.e11–683.e18. 4 indexed citations

Wang, Jing, Zihao Ma, Steven A. Carr, et al.. (2016). Proteome Profiling Outperforms Transcriptome Profiling for Coexpression Based Gene Function Prediction. Molecular & Cellular Proteomics. 16(1). 121–134. 94 indexed citations

Li, Danni, et al.. (2012). Validation of a multiplex immunoassay for serum angiogenic factors as biomarkers for aggressive prostate cancer. Clinica Chimica Acta. 413(19-20). 1506–1511. 25 indexed citations

Marzinke, Mark A., Caitlin H. Choi, Li Chen, et al.. (2012). Proteomic Analysis of Temporally Stimulated Ovarian Cancer Cells for Biomarker Discovery. Molecular & Cellular Proteomics. 12(2). 356–368. 20 indexed citations

Loeb, Stacy, Edward M. Schaeffer, Daniel W. Chan, et al.. (2009). Investigation of Human Anti-mouse Antibodies as Potential Cause of Postprostatectomy PSA Elevation. Urology. 73(5). 947–949. 2 indexed citations

Yoshimura, Toru, Rahul Patil, Gangamani S. Beligere, et al.. (2009). Development and analytical performance evaluation of an automated chemiluminescent immunoassay for pro-gastrin releasing peptide (ProGRP). Clinical Chemistry and Laboratory Medicine (CCLM). 47(12). 1557–63. 12 indexed citations

Zhang, Zhen, Yinhua Yu, Fengji Xu, et al.. (2007). Combining multiple serum tumor markers improves detection of stage I epithelial ovarian cancer. Gynecologic Oncology. 107(3). 526–531. 80 indexed citations

Chan, Daniel W., et al.. (2007). Enzymes and related proteins as cancer biomarkers: A proteomic approach. Clinica Chimica Acta. 381(1). 93–97. 62 indexed citations

Alex, J., Paul M. Stemmer, Zhen Zhang, et al.. (2005). Analysis of Human Proteome Organization Plasma Proteome Project (HUPO PPP) reference specimens using surface enhanced laser desorption/ionization‐time of flight (SELDI‐TOF) mass spectrometry: Multi‐institution correlation of spectra and identification of biomarkers. PROTEOMICS. 5(13). 3467–3474. 72 indexed citations

10.

Zhang, Zhen, et al.. (2004). Protein identification and immunoassay evaluation of a panel of biomarkers discovered through proteomic profiling for the detection of ovarian cancer. Cancer Research. 64. 242–242.

11.

Chan, Daniel W., et al.. (2004). The Use of Laser Capture Microscopy in Proteomics Research – A Review. Disease Markers. 20(3). 155–160. 13 indexed citations

12.

Sokoll, Lori J., Leslie A. Mangold, Alan W. Partin, et al.. (2002). Complexed prostate-specific antigen as a staging tool for prostate cancer: a prospective study in 420 men. Urology. 60(4). 18–23. 12 indexed citations

13.

Sokoll, Lori J. & Daniel W. Chan. (1998). Total, free, and complexed PSA: Analysis and clinical utility. 21(2). 171–179. 11 indexed citations

14.

Bruzek, Debra J., et al.. (1998). Clinical Evaluation Comparing AxSYM® CA 15-3TM, IMx® CA 15-3 and Truquant® BRTM RIA. Tumor Biology. 19(6). 421–438. 8 indexed citations

15.

Green, Gary B., et al.. (1998). Use of Troponin T and Creatine Kinase-MB Subunit Levels for Risk Stratification of Emergency Department Patients With Possible Myocardial Ischemia. Annals of Emergency Medicine. 31(1). 19–29. 37 indexed citations

16.

Pearson, Jay D., Albert A. Luderer, E. Jeffrey Metter, et al.. (1996). Longitudinal analysis of serial measurements of free and total PSA among men with and without prostatic cancer. Urology. 48(6). 4–9. 52 indexed citations

17.

Carter, H. Ballentine, Jay D. Pearson, E. Jeffrey Metter, et al.. (1995). Longitudinal evaluation of serum androgen levels in men with and without prostate cancer. The Prostate. 27(1). 25–31. 107 indexed citations

18.

Hsu, Chaur-Dong, et al.. (1994). Elevated serum human chorionic gonadotropin as evidence of secretory response in severe preeclampsia. American Journal of Obstetrics and Gynecology. 170(4). 1135–1138. 78 indexed citations

19.

Chan, Daniel W. & M.T. Perlstein. (1987). Immunoassay : a practical guide. Academic Press eBooks. 137 indexed citations

20.

Belizán, José M., et al.. (1983). Preliminary evidence of the effect of calcium supplementation on blood pressure in normal pregnant women. American Journal of Obstetrics and Gynecology. 146(2). 175–180. 100 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact